Translational Cancer Research
期刊信息导读
- Translational Cancer Research基本信息
- Translational Cancer Research中科院SCI期刊分区
- 历年Translational Cancer Research影响因子趋势图
- Translational Cancer Research期刊英文简介
- Translational Cancer Research期刊中文简介
Translational Cancer Research基本信息
简称：Transl Cancer Res
中文名称：转化癌症研究
研究方向：医学
2018-2019最新影响因子：1.07
2022年6月28日更新影响因子：0.496
SCI类别：SCIE
是否OA开放访问：No
出版地：PEOPLES R CHINA
年文章数：203
涉及的研究方向：医学-肿瘤学
官方网站：http://tcr.amegroups.com/
投稿网址：http://tcr.amegroups.com/login?source=%2Fauthor%2Fsubmit
PMC链接：http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2218-676X%5BISSN%5D
Translational Cancer Research期刊英文简介
Translational Cancer Research (Transl Cancer Res TCR; Print ISSN: 2218-676X; Online ISSN 2219-6803; www.thetcr.org) is an Open Access, peer-reviewed journal, published by AME Publishing Company, publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of cancer patients. TCR will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. The focus of TCR is original, peer-reviewed, science-based research that successfully advances clinical medicine toward the goal of improving cancer patients lives. The editors and an international advisory group of scientists and clinician-scientists as well as other experts will hold TCR articles to the high-quality standards. We accept Original Articles as well as Review Articles, Editorials and Brief Articles. The Official Publication of Society for Translational Cancer Research (STCR),Hong Kong
Translational Cancer Research期刊中文简介
转化性癌症研究（Transl Cancer Res-TCR；印刷ISSN:2218-676X；在线ISSN 2219-6803；www.the tcr.org）是一个开放的、同行评审的期刊，由AME出版公司出版，发表了连接实验室和临床环境的新型研究调查结果，包括风险评估、细胞和分子。以提高癌症患者临床护理水平为总体目标，对人类癌症进行定性、预防、检测、诊断和治疗。TCR将公布新的治疗干预措施的实验室研究以及评估癌症新治疗模式的临床试验。TCR的重点是原始的、同行评审的、基于科学的研究，该研究成功地将临床医学推向改善癌症患者生活的目标。编辑和一个由科学家和临床医生科学家以及其他专家组成的国际咨询小组将把TCR文章保持在高质量标准。我们接受原创文章以及评论文章、社论和简短文章。香港翻译癌症研究学会官方刊物。
中科院SCI期刊分区：
Translational Cancer Research影响因子
获取相关优质资源
获取2023中科院分区
![goback](data:image/svg+xml;charset=utf-8,<svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 20"><path d="M10,0l2,2l-8,8l8,8l-2,2L0,10L10,0z" fill="%23fff"/></svg>){kind=icon}
